MED 📈 MEDIFAST INC - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US58470H1014
MED: Weight Loss, Nutrition, Bars, Drinks, Soups, Shakes
Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland. Web URL: https://medifastinc.com
Additional Sources for MED Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
MED Stock Overview
| Market Cap in USD | 215m |
| Sector | Consumer Cyclical |
| Industry | Personal Services |
| GiC Sub-Industry | Personal Care Products |
| IPO / Inception | 1993-12-31 |
MED Stock Ratings
| Growth 5y | -87.3% |
| Fundamental | -20.5% |
| Dividend | 28.9% |
| Rel. Strength Industry | -561 |
| Analysts | 3/5 |
| Fair Price Momentum | 15.18 USD |
| Fair Price DCF | 80.02 USD |
MED Dividends
| Dividend Yield 12m | 0.00% |
| Yield on Cost 5y | % |
| Annual Growth 5y | -100.00% |
| Payout Consistency | 97.5% |
MED Growth Ratios
| Growth Correlation 3m | 24.1% |
| Growth Correlation 12m | -90.3% |
| Growth Correlation 5y | -62.6% |
| CAGR 5y | -28.36% |
| CAGR/Mean DD 5y | -0.58 |
| Sharpe Ratio 12m | -2.33 |
| Alpha | -101.28 |
| Beta | 1.03 |
| Volatility | 48.86% |
| Current Volume | 483.9k |
| Average Volume 20d | 246k |
What is the price of MED stocks?
As of December 22, 2024, the stock is trading at USD 16.92 with a total of 483,945 shares traded.
Over the past week, the price has changed by -11.69%, over one month by -6.83%, over three months by -9.42% and over the past year by -74.75%.
As of December 22, 2024, the stock is trading at USD 16.92 with a total of 483,945 shares traded.
Over the past week, the price has changed by -11.69%, over one month by -6.83%, over three months by -9.42% and over the past year by -74.75%.
Is MEDIFAST INC a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, MEDIFAST INC is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -20.54 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MED as of December 2024 is 15.18. This means that MED is currently overvalued and has a potential downside of -10.28%.
Neither. Based on ValueRay Fundamental Analyses, MEDIFAST INC is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -20.54 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MED as of December 2024 is 15.18. This means that MED is currently overvalued and has a potential downside of -10.28%.
Is MED a buy, sell or hold?
MEDIFAST INC has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold MED.
MEDIFAST INC has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold MED.
- Strong Buy: 0
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecast for MED stock price target?
According to ValueRays Forecast Model, MED MEDIFAST INC will be worth about 16.8 in December 2025. The stock is currently trading at 16.92. This means that the stock has a potential downside of -0.71%.
According to ValueRays Forecast Model, MED MEDIFAST INC will be worth about 16.8 in December 2025. The stock is currently trading at 16.92. This means that the stock has a potential downside of -0.71%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 16.5 | -2.5% |
| Analysts Target Price | 81 | 378.7% |
| ValueRay Target Price | 16.8 | -0.7% |